ResMed Inc (RSMDF) stock
RSMDFOTCSurgical & Medical Instruments & ApparatusFiscal year ends June 30Also trades as RMD
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Aug 13, 2026Score 21/3011% below fair value
$22.61+0.00 (0.00%)
Close on Oct 19, 2026Market cap $33.17BP/E 22.0Yield 1.04%
ResMed gross margin
Gross margin is gross profit as a percentage of revenue.
ResMed's gross margin for the twelve months ending Jun 30, 2026 was 61.1%. For fiscal 2026 it was 61.1%, against 59.4% the year before. The highest annual figure on record is 63.7% in fiscal 2014.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | 61.1% | +1.7 |
| FY2025 | Jun 30, 2025 | 59.4% | +2.7 |
| FY2024 | Jun 30, 2024 | 56.7% | +0.9 |
| FY2023 | Jun 30, 2023 | 55.8% | −0.8 |
| FY2022 | Jun 30, 2022 | 56.6% | −1.0 |
| FY2021 | Jun 30, 2021 | 57.5% | −0.6 |
| FY2020 | Jun 30, 2020 | 58.1% | +0.8 |
| FY2019 | Jun 30, 2019 | 57.3% | +0.3 |
| FY2018 | Jun 30, 2018 | 57.0% | −1.1 |
| FY2017 | Jun 30, 2017 | 58.1% | +0.1 |
| FY2016 | Jun 30, 2016 | 58.0% | −2.2 |
| FY2015 | Jun 30, 2015 | 60.2% | −3.4 |
| FY2014 | Jun 30, 2014 | 63.7% | +1.5 |
| FY2013 | Jun 30, 2013 | 62.1% | +2.1 |
| FY2012 | Jun 30, 2012 | 60.0% | +0.3 |
| FY2011 | Jun 30, 2011 | 59.6% | −0.4 |
| FY2010 | Jun 30, 2010 | 60.0% | −0.1 |
| FY2009 | Jun 30, 2009 | 60.1% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2026 | Jun 30, 2026 | 58.8% | −2.0 |
| Q3 FY2026 | Mar 31, 2026 | 62.2% | +2.9 |
| Q2 FY2026 | Dec 31, 2025 | 61.8% | +3.2 |
| Q1 FY2026 | Sep 30, 2025 | 61.5% | +2.9 |
| Q4 FY2025 | Jun 30, 2025 | 60.8% | +2.3 |
| Q3 FY2025 | Mar 31, 2025 | 59.3% | +1.5 |
| Q2 FY2025 | Dec 31, 2024 | 58.6% | +3.0 |
| Q1 FY2025 | Sep 30, 2024 | 58.6% | +4.1 |
| Q4 FY2024 | Jun 30, 2024 | 58.5% | +3.5 |
| Q3 FY2024 | Mar 31, 2024 | 57.9% | +2.6 |
| Q2 FY2024 | Dec 31, 2023 | 55.6% | −0.4 |
| Q1 FY2024 | Sep 30, 2023 | 54.4% | −2.5 |
| Q4 FY2023 | Jun 30, 2023 | 55.0% | −2.1 |
| Q3 FY2023 | Mar 31, 2023 | 55.3% | −1.5 |
| Q2 FY2023 | Dec 31, 2022 | 56.1% | −0.3 |
| Q1 FY2023 | Sep 30, 2022 | 56.9% | +0.9 |
| Q4 FY2022 | Jun 30, 2022 | 57.1% | +1.1 |
| Q3 FY2022 | Mar 31, 2022 | 56.8% | −1.4 |
| Q2 FY2022 | Dec 31, 2021 | 56.4% | −1.5 |
| Q1 FY2022 | Sep 30, 2021 | 56.0% | −2.3 |
| Q4 FY2021 | Jun 30, 2021 | 56.0% | −2.3 |
| Q3 FY2021 | Mar 31, 2021 | 58.2% | −0.3 |
| Q2 FY2021 | Dec 31, 2020 | 57.8% | −0.2 |
| Q1 FY2021 | Sep 30, 2020 | 58.3% | +0.8 |
| Q4 FY2020 | Jun 30, 2020 | 58.3% | +1.2 |
| Q3 FY2020 | Mar 31, 2020 | 58.4% | +0.9 |
| Q2 FY2020 | Dec 31, 2019 | 58.0% | +0.5 |
| Q1 FY2020 | Sep 30, 2019 | 57.5% | −0.8 |
| Q4 FY2019 | Jun 30, 2019 | 57.1% | +3.3 |
| Q3 FY2019 | Mar 31, 2019 | 57.5% | −0.7 |
| Q2 FY2019 | Dec 31, 2018 | 57.5% | −0.7 |
| Q1 FY2019 | Sep 30, 2018 | 58.3% | −0.0 |
| Q4 FY2018 | Jun 30, 2018 | 53.8% | −4.4 |
| Q3 FY2018 | Mar 31, 2018 | 58.2% | −0.1 |
| Q2 FY2018 | Dec 31, 2017 | 58.2% | −0.1 |
| Q1 FY2018 | Sep 30, 2017 | 58.4% | +0.5 |
| Q4 FY2017 | Jun 30, 2017 | 58.2% | – |
| Q3 FY2017 | Mar 31, 2017 | 58.3% | – |
| Q2 FY2017 | Dec 31, 2016 | 58.3% | – |
| Q1 FY2017 | Sep 30, 2016 | 57.8% | – |